DIRS.INFO The most relevant business & tech news

☆ Jim Cramer's Investing Club meeting Thursday: Jobs report, Danaher, Honeywell
▼ + stars: | 2023-03-09 | by ( Paulina Likos | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Look to jobs report Stocks edged up in midmorning trading Thursday, helped by softer bond yields. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

☆ Here’s our Annual Meeting update on the 7 health care and bank stocks in the Club portfolio
▼ + stars: | 2023-03-01 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +7 min

Here's an update on the health care and financial holdings in Jim Cramer's Charitable Trust, the portfolio we use at the CNBC Investing Club. At levels below $250 per share, Jim said Danaher is one of the most attractive stocks in the Club's portfolio. Its consumer-products unit will become a company known as Kenvue, while its faster-growing pharmaceutical and medical devices divisions will retain the J & J name. However, there is some litigation risk with J & J after a federal judge in January rejected its strategy concerning more than 38,000 talc lawsuits. Against that backdrop, we view J & J as a quality defensive name to own, especially given its annual dividend yield of around 3%.

☆ Is ChatGPT the tip of the iceberg? Analysts reveal potential A.I. uses — and the stocks to play it
▼ + stars: | 2023-03-01 | by ( Zavier Ong | ) www.cnbc.com time to read: +3 min

ChatGPT is considered by far the most successful generative AI tool to date. But while ChatGPT is undoubtedly the talk of the town, HSBC believes it could just be the tip of the generative AI iceberg. However, there is the potential for Generative AI to have a significant impact on several sectors of the economy," the bank said. How to play it Morgan Stanley has named a raft of global stocks to play generative AI. Medical diagnostics Meanwhile, Canaccord Genuity in a Feb. 20 note highlighted the implications of AI on the medical diagnostics sector.

☆ We're adding to our position in this robust medical technology player
▼ + stars: | 2023-02-28 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

We are buying 15 shares of Danaher (DHR) at roughly $248.34 apiece. Following Tuesday's trade, Jim Cramer's Charitable Trust will own 495 shares of DHR, increasing its weighting in the portfolio to about 4.76% from 4.62%. Despite the company's strong fourth-quarter earnings beat in January, shares of Danaher are down about 11% since late January. DHR 1Y mountain Danaher (DHR) one-year performance. (Jim Cramer's Charitable Trust is long DHR.

☆ Erythritol, an ingredient in stevia, linked to heart attack and stroke, study finds
▼ + stars: | 2023-02-27 | by ( Sandee Lamotte | ) edition.cnn.com time to read: +9 min

CNN —A sugar replacement called erythritol — used to add bulk or sweeten stevia, monkfruit and keto reduced-sugar products — has been linked to blood clotting, stroke, heart attack and death, according to a study. “If your blood level of erythritol was in the top 25% compared to the bottom 25%, there was about a two-fold higher risk for heart attack and stroke,” Hazen said. Clots can break off and travel to the heart, triggering a heart attack, or to the brain, triggering a stroke. “There appears to be a clotting risk from using erythritol,” Freeman said. In all three populations, researchers found that higher levels of erythritol were connected to a greater risk of heart attack, stroke or death within three years.

Persons: ”, Stanley Hazen, ” Hazen, “, erythritol, Andrew Freeman, ” Freeman, Robert Rankin, ” Rankin, Hazen, “ It’s, Erythritol, Hazen’s, Oliver Jones, ” Jones, You’ll, Health’s Freeman Organizations: CNN, Center for Cardiovascular Diagnostics, Cleveland Clinic Lerner Research Institute, People, Nature, Jewish Health, European Association of Polyol, Cleveland Clinic’s Center, Human, RMIT University, National Health, European Food Safety Authority, Food and Drug Administration Locations: Denver, United States, Europe, erythritol, Australia

☆ This little-known health stock that uses A.I. can rally more than 120%, Canaccord Genuity says
▼ + stars: | 2023-02-22 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

Oncology stock Guardant Health could be a big winner in the ChatGPT-driven artificial intelligence frenzy, according to Canaccord Genuity. Canaccord anticipates Guardant Health will see some upside, boosted by its AI-related suite of technology the company announced in January . ChatGPT also could enable 24-hour/7-day access to healthcare services," Mikson wrote. Guardant Health last month announced the launch of its Guardant Galaxy platform, which includes technologies that will aid in the company's tests and enable biomarker and drug discovery. The first application in the company's product suite is an AI-backed digital-pathology platform developed by Lunit, a South Korea-based company.

☆ Here's how Wall Street pros traded 13 Club stocks last quarter, including Salesforce and Disney
▼ + stars: | 2023-02-17 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +9 min

Big-name investors and hedge funds made moves in Club holdings Disney (DIS), Nvidia (NVDA) and TJX Companies (TJX) in the fourth quarter. Starboard's position stood at 3.03 million shares — valued at $401.22 million — at the end of the fourth quarter, according to the firm's 13F. Inclusive's 1.63 million shares were worth $216.77 million and ValueAct's 560,221 shares carried a market value of $74.28 million. CRM YTD mountain Salesforce (CRM) YTD performance In addition to Salesforce, a number of other Club holdings appeared in hedge funds' quarterly disclosures. Some of the activists swarming at Salesforce have positions in other Club holdings and made changes to them during the fourth quarter.

☆ In EU car data tussle, insurers and others brace for delays, disappointment
▼ + stars: | 2023-02-16 | by ( Nick Carey | ) www.reuters.com time to read: +4 min

Companies in Europe and beyond are vying for control of the crown jewels of the connected car era, namely car manufacturers' data covering everything from driving habits, to fuel consumption and tyre wear which can be used to target cash-generating services. Although the EU is currently haggling over the Data Act, a draft law governing the use of consumer and corporate data, insurers and others are pushing for auto sector-specific regulation. A proposal is expected soon after the European Commission launched a consultation last year. Ten industry groups also wrote to European Commission President Ursula von der Leyen in January urging an end to "repeated delays". A spokesperson for the European Automobile Manufacturers Association (ACEA) said the Data Act would guarantee fair access to car data, so "additional legislation on access to in-vehicle data is unlikely to achieve more".

☆ Small caps are on a tear this year. Here’s how investors are playing the rally.
▼ + stars: | 2023-02-16 | by ( Pia Singh | ) www.cnbc.com time to read: +6 min

"A regime change, if you will, is taking place in the market, where small caps are going to do better," said Francis Gannon, co-chief investment officer at Royce Investment Partners, which focuses on small caps. Now investors are pointing to the recent rally as proof that small caps are on the verge of a prolonged period of outperformance. 'Massively outperform' Michael Sesser, equity portfolio manager of the $558-million DWS Small Cap Core fund, believes small caps will "massively outperform" large caps over the next five to 10 years. Cantaloupe , a retail service digital payments company with a $373 million market cap, and medical imaging provider RadNet ($1.2 billion market cap) are among Sesser's picks. DWS Small Cap also owns metallurgical coal producers serving the steel industry, namely Alpha Metallurgical Resources ($2.7 billion market cap), Arch Resources ($2.6 billion market cap) and Peabody Energy ($4.2 billion market cap).

☆ As ChatGPT mania takes hold, here's how companies beyond tech are using A.I.
▼ + stars: | 2023-02-08 | by ( Samantha Subin | ) www.cnbc.com time to read: +7 min

AI's been in use for years, of course, helping companies improve products, efficiency and their business models. Media conglomerate Comcast (the parent of CNBC) is harnessing AI to improve expenses and innovate within high-speed broadband, while Stanley Black & Decker mentioned it's using AI to help customers better measure the hardening of concrete. Here's how some of the biggest companies outside of technology are utilizing AI to improve their businesses: Healthcare companies bet on AI One of the biggest beneficiaries of the latest AI trends might be healthcare companies. Some health companies also view machine learning and AI as tools to assist in areas with doctor shortages or fewer resources. Minneapolis-based utility Xcel Energy said it's using AI technology to improve efficiency at its plants and move from "reactive to proactive maintenance," said Brian Van Abel, Xcel's chief financial officer.

☆ Here’s our February rapid-fire update on all 34 stocks in Jim Cramer’s Investing Club portfolio
▼ + stars: | 2023-02-05 | by ( Matthew J. Belvedere | ) www.cnbc.com time to read: +12 min

Here's a rapid-fire update on all 34 stocks in Jim Cramer's Charitable Trust, the holdings we manage in the CNBC Investing Club. J & J is a good stock to get into ahead of the impending split into two companies: consumer brands and pharma/medical technology. The company reported a good quarter and guidance, while fundamentals are solid ahead of the split. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

☆ Roche flags 2023 earnings decline on slump in COVID products
▼ + stars: | 2023-02-02 | by ( Ludwig Burger | ) www.reuters.com time to read: +1 min

Last year, group revenue edged 1% higher to 63.3 billion Swiss francs ($69.78 billion), the company reported, beating market expectations of 63.2 billion francs, while core operating profit gained 1% to 22.2 billion Swiss francs, just shy of the average analyst estimate of 22.4 billion francs. The onus to reinvigorate the pipeline will be on chief executive officer-designate Thomas Schinecker, who is Roche's head of diagnostics, and due to be promoted to group CEO in March. In the wake of Schinecker's appointment, the head of Roche's pharmaceuticals division, Bill Anderson, decided in December to leave after 16 years with the Swiss drugmaker. Roche said on Thursday that Teresa Graham, currently Head of Global Product Strategy for Roche Pharmaceuticals, would succeed Anderson. ($1 = 0.9071 Swiss francs)Reporting by Ludwig Burger; Editing by Paul Carrel and Rashmi AichOur Standards: The Thomson Reuters Trust Principles.

☆ World Trade Organization head wants to 'double or triple' Africa's share of global trade
▼ + stars: | 2023-02-02 | by ( Nell Lewis | ) edition.cnn.com time to read: +5 min

The World Trade Organization (WTO) projected in October that after growing by 3.5% in 2022, trade volumes will increase by just 1% in 2023. Either way, Africa may start to reap the benefits of a free trade deal that came into effect in 2021. The landmark African Continental Free Trade Area (AfCFTA) agreement created the world’s largest new free trade area since the establishment of the WTO. What do they need and what are they telling you in terms of doing cross-border trade on the African continent? What we’ve seen during the pandemic is that Africa needs to get its own manufacturing capacity, and this falls right back into what can make the continental free trade area work.

☆ Tyler Burnett turned a toothache into a VC-backed company. Here's an exclusive look at the pitch deck he used to raise $3 million for dental startup Wally Health.
▼ + stars: | 2023-02-02 | by ( April Joyner | Samantha Stokes | ) www.businessinsider.com time to read: +3 min

The startup Wally Health provides dental cleanings and preventative care for $199 a year. Take a look at the pitch deck Wally used to raise a $3 million seed round led by Bling Capital. That experience inspired the creation of his startup, Wally Health, which has raised $3 million in a seed round led by Bling Capital. Years before Wally, Burnett had launched businesses in media and fintech back in his native Canada. After raising a pre-seed round, Burnett and his cofounders started building Wally's proof of concept about a year ago in an office in New York's Upper East Side.

☆ Illumina Makes Its Interim CFO Permanent
▼ + stars: | 2023-02-01 | by ( Kristin Broughton | ) www.wsj.com time to read: +3 min

Gene-sequencing company Illumina Inc. on Wednesday named Joydeep Goswami as chief financial officer, giving its interim CFO the role on a permanent basis. Mr. Goswami joined Illumina in 2019 as chief strategy and corporate development officer, overseeing strategic partnerships and acquisitions. Illumina CFO Joydeep Goswami. He added that he received a crash course in traditional areas of finance, including treasury, tax and audit, while serving as interim CFO. As CFO, Mr. Goswami plans to keep Illumina’s spending on innovation roughly constant as a percentage of revenue.

LONDON/GENEVA, Feb 1 (Reuters) - Governments may have to reserve drugs and vaccines for the World Health Organization to distribute in poorer countries to avoid a repeat of the "catastrophic failure" during the COVID-19 pandemic, according to an early draft of a global pandemic agreement. The agreement, which is commonly known as the pandemic treaty, has been drawn up by WHO member states and will now go through a lengthy negotiating process before being finalised. Talks on the draft treaty will begin on Feb. 27 and are set to continue to 2024. However, there will be "heat and opposition" in the negotiations ahead, particularly around the intellectual property provisions, said James Love, director of the NGO Knowledge Ecology International. The draft also calls for a new WHO Global Pandemic Supply Chain and Logistics Network to ensure better and fairer distribution of counter-measures, as well as a global compensation scheme for vaccine injuries.

☆ The best acne treatment for teens, according to dermatologists
▼ + stars: | 2023-01-27 | by ( Vivian Manning-Schaffel | ) www.nbcnews.com time to read: +10 min

| How to treat teen acne | What makes teen acne worse? To help you find the right products for you, we spoke to dermatologists about teen acne treatments and ingredients to look for. The best treatments for teen acne to shop, according to expertsBelow, we gathered expert-recommended face washes and spot treatments that can help improve teen acne. It’s fragrance-free, non-comedogenic and should remove any excess oil, dirt or makeup from the skin, according to the brand. Making sure to minimize or avoid ways that could make acne worse is the key to reducing breakouts, according to our experts.

☆ Artificial intelligence and machine learning are helping companies provide even better service for customers
▼ + stars: | 2023-01-27 | by ( Sponsor Post | Created Hitachi With Insider Studios | ) www.businessinsider.com time to read: +7 min

By harnessing Hitachi's advanced expertise in artificial intelligence (AI) and machine learning (ML), the partners took their existing model and expanded it into a predictive model they called Proactive Diagnostics. The Guided Repair solution is now being used by more than 9,700 Penske fleet maintenance technicians in more than 880 locations. Using machine learning, the Proactive Diagnostics solution monitors fleet vehicles and tracks anomalies that indicate future potential failures." The Proactive Diagnostics solution provides data archived over days and weeks to give Penske that predictive power so it can act on its knowledge. With its enhanced capacity for analysis, Proactive Diagnostics enables Penske to compare fault codes and search for patterns that signal a potential failure.

☆ Stocks may face an inflection point in the week ahead as the Fed meets and Apple posts earnings
▼ + stars: | 2023-01-27 | by ( Patti Domm | In | ) www.cnbc.com time to read: +9 min

The Fed's meeting Tuesday and Wednesday comes amid a flood of corporate earnings reports, with about 20% of the S & P 500 reporting that week. The most important day for earnings is Thursday, when Apple , Alphabet and Amazon report after the bell. The Nasdaq Composite was up 11% for the month as of Friday afternoon, well ahead of the 6.2% gain in the S & P 500. Traders have been watching the S & P 500 edge closer to the key threshold of 4,100 , its high from December. AAPL 1Y line apple Apple is also important because of the signals it can send about the strength of the consumer, supply chains and China's reopening.

Autism rates tripled among children in the New York and New Jersey metropolitan area from 2000 to 2016, according to a study published Thursday in the journal Pediatrics. Although there is no medical test for autism, the CDC has established a network of 17 sites across the country that estimate autism rates based on a combination of formal medical diagnoses and records from schools and health care providers. Nationally, the rise in autism rates has been similar to the trend in New York and New Jersey, according to a 2021 CDC report. But there’s probably more to the story: Genetic factors, and perhaps some environmental ones, too, might also be contributing to the trend. Beyond the improvements in diagnostics, genetic factors could be driving up autism cases on their own, experts said.

☆ Jim Cramer's top 8 things to watch in the market Wednesday: Microsoft, 3M, Boeing earnings
▼ + stars: | 2023-01-25 | by ( Jim Cramer | ) www.cnbc.com time to read: +4 min

Lots of price target cuts by Wall Street analysts, but they largely keep their buy ratings. Baird keeps Danaher (DHR) at an overweight (buy) rating but cuts price target to $309 per share from $321. Barclays raises price target on SLB (SLB) to $74 per share from $62. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER .

☆ Bill Gates says no country ‘gets an A’ for its Covid pandemic response—including the U.S.
▼ + stars: | 2023-01-25 | by ( Tom Huddleston Jr. | ) www.cnbc.com time to read: +3 min

Bill Gates says some of the world's governments have handled the spread of Covid-19 better than others, but the billionaire won't give any country a perfect mark. The Microsoft co-founder and health care philanthropist has both praised and criticized multiple world governments' responses to the pandemic since the coronavirus's initial spread in late 2019. Poor Covid responses inspired government spending on future pandemic preparedness in multiple countries, he observed. Gates also applauded Australia's pandemic response last year, noting that the country quickly closed its international borders in March 2020. The U.S. gave that money to companies in multiple countries, resulting in multiple effective Covid vaccines.

☆ Abbott's medical device sales hit by China curbs, supply-chain issues
▼ + stars: | 2023-01-25 | by ( Leroy Leo | ) www.reuters.com time to read: +2 min

Jan 25 (Reuters) - Abbott Laboratories (ABT.N) on Wednesday reported lower-than-expected medical device sales in the fourth quarter as COVID-19 curbs in China and supply-chain issues hit its international operations, dragging shares 2.5% lower in premarket trading. The multinational healthcare giant recorded an overall medical device sales of $3.75 billion, missing analysts' average estimate of $3.84 billion. The company, however, posted a better-than-expected quarterly profit, underpinned by strong demand for its diagnostics business and glucose monitoring device FreeStyle Libre. Freestyle Libre has been driving the sales of Abbott's medical devices, offsetting a decline in COVID-19 diagnostic test sales as infections wane. The company recorded $1.1 billion each in sales of FreeStyle Libre and COVID-testing related sales.

☆ Jim Cramer's top 10 things to watch in the market Tuesday: Club earnings, AMD downgrade, Disney hope
▼ + stars: | 2023-01-24 | by ( Jim Cramer | ) www.cnbc.com time to read: +3 min

Three quarterly reports before the bell and Club holding Microsoft (MSFT) after the close. Club holding Nvidia (NVDA): Citi sees generative artificial intelligence ChatGPT as a $5 billion to $11 billion opportunity. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

☆ Danaher's stock drop looks like a buying opportunity after it reported a solid quarter
▼ + stars: | 2023-01-24 | by ( Zev Fima | ) www.cnbc.com time to read: +7 min

When excluding the impact of declining Covid testing sales — but keeping in revenue from products that support vaccines and therapeutics — Danaher's base business saw core growth of 7.5%. Guidance Management expects overall core revenue growth to be down mid-single-digits on a percentage for the first quarter. For the full year 2023, management expects overall core revenue growth to be down mid-single-digits. Previously, only revenues related to Covid testing were excluded. On the call, management pointed to roughly 10% core revenue growth in both North America and Europe.

Search resuls for: "Diagnostics"

25 mentions found